Angelo Adamo

Implementation of a quality management system according to ISO 9001:2015 standards in an Angiology Unit: an Italian experience.

Giampiero Avruscio, Sonia Ragazzo, D. Ceccato, Angelo Adamo et autres

Background: The International Standardization Organization operates the world's most widely recognized quality management system standard, the ISO 9001:2015. In the healthcare sector, the adoption of this standard within an organization helps to improve the overall performance and provides a foundation for development …

it, es (code pays fourni par la source)

Wound Care During the COVID-19 Emergency in Padua Hospital, Italy

Giampiero Avruscio, Angelo Adamo, Chiara Tonello, Elisabetta Baracco et autres

Chronic vascular wounds have a significant economic and social impact on our society, calling for the allocation of a great deal of attention and resources. The coronavirus disease (COVID-19) outbreak has represented a difficult challenge to face for health care providers and …

it (code pays fourni par la source)

Challenging arterial calcification disease associated with rare NT5E gene mutation

Giampiero Avruscio, Mauro Massussi, Angelo Adamo, Alfredo Brusco

A 47-year-old woman has been suffering from intermittent claudication since she was 33 years old. The symptoms have slowly worsened during the following years and the patient was unable to walk more than 200 m without leg pain (Leriche-Fontain IIb) at admission. …

it (code pays fourni par la source)

Thrombophilia, risk factors and prevention

Elena Campello, Luca Spiezia, Angelo Adamo, Paolo Simioni

INTRODUCTION: Fifty-three years after the first description of an inherited prothrombotic condition (antithrombin deficiency), our knowledge on hereditary and acquired causes of hypercoagulability that can predispose carriers to venous thromboembolism (VTE) has greatly improved. Areas covered: Main causes of hereditary thrombophilia are …

it (code pays fourni par la source)

Failure of old and new anticoagulants to prevent ischemic stroke in high-risk atrial fibrillation: a case report.

Franca Bilora, Angelo Adamo, Fabio Pomerri, Paolo Prandoni

Rivaroxaban is an oral anticoagulant that acts as a direct, competitive factor Xa inhibitor. Large randomized clinical trials have shown that, at a daily dose of 20 mg, Rivaroxaban is at least as effective as dose-adjusted warfarin for the prevention of stroke …

it (code pays fourni par la source)

An unusual finding of massive pulmonary embolism in a patient during treatment with high-dose ibuprofen

Franca Bilora, Angelo Adamo, Fabio Pomerri, Paolo Prandoni

it (code pays fourni par la source)

Venous and Arterial Thrombosis: Is there a Link?

Paolo Prandoni, Marta Milan, Valentina Vedovetto, Lucia Sarolo et autres

An increasing body of evidence suggests the likelihood of a link between venous and arterial thrombosis. The two vascular complications share several risk factors, such as age, obesity, smoking, diabetes mellitus, blood hypertension, hypertriglyceridemia, and metabolic syndrome. Moreover, there are many examples …

it (code pays fourni par la source)

Abstract 11694: The Gut Hormone Obestatin Induces Nitric Oxide-Dependent Vasodilation and Inhibits Endothelin-1 Activity in Obese Patients

Francesca Schinzari, Manfredi Tesauro, Angelo Adamo, Alessandra Paolucci et autres

Obese patients have vascular dysfunction related to impaired nitric oxide (NO)-dependent vasodilation and increased endothelin (ET)-1 activity. Obestatin is a gastrointestinal peptide with favorable metabolic actions linked to obesity and diabetes; it has also been shown to exert cardiovascular benefits in experimental …

it, us (code pays fourni par la source)

Endothelin-dependent vasoconstrictor activity in metabolically healthy and unhealthy obese patients

Carmine Cardillo, Francesca Schinzari, Angelo Adamo, Valentina Rovella et autres

Therefore, we investigated oxidative stress levels in AMI patients with lipophilic atorvastatin or hydrophilic pravastatin.Methods and results: The study population included a prospective, randomized, open-label, study in AMI patients within ALPS-AMI study.Patients that have undergone successful percutaneous coronary intervention will be randomly …

it (code pays fourni par la source)

Effects of GLP-1 on Forearm Vasodilator Function and Glucose Disposal During Hyperinsulinemia in the Metabolic Syndrome

Manfredi Tesauro, Francesca Schinzari, Angelo Adamo, Valentina Rovella et autres

OBJECTIVE: Patients with the metabolic syndrome (MetS) have impaired insulin-induced enhancement of vasodilator responses. The incretin hormone glucagon-like peptide 1 (GLP-1), beyond its effects on blood glucose, has beneficial actions on vascular function. This study, therefore, aimed to assess whether GLP-1 affects …

it, us (code pays fourni par la source)

Coexistence of functional angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans

Francesca Schinzari, Manfredi Tesauro, Valentina Rovella, Angelo Adamo et autres

OBJECTIVES: Angiotensin (Ang) II type 1 (AT₁) receptors mediate the majority of cardiovascular effects of Ang II, whereas the role of type 2 (AT₂) receptors is still controversial. The present study, therefore, investigated regional hemodynamic responses mediated by AT₂ receptors in humans. …

it (code pays fourni par la source)

RHO-KINASE INHIBITION IMPROVES NITRIC OXIDE-DEPENDENT VASODILATOR REACTIVITY DURING HYPERINSULINEMIA IN PATIENTS WITH METABOLIC SYNDROME

Francesca Schinzari, Manfredi Tesauro, Valentina Rovella, Paolo Gentileschi et autres

Schinzari, F.1; Tesauro, M.2; Rovella, V.2; Gentileschi, P.3; Mores, N.4; Adamo, A.1; Cardillo, C.1 Author Information

it (code pays fourni par la source)